tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Jazz Pharmaceuticals PLC

JAZZ
Add to Watchlist
252.860USD
-5.520-2.14%
Close 07-31 16:00（ET）Quotes delayed by 15 min
15.53BMarket Cap
613.23P/E TTM

Jazz Pharmaceuticals PLC

252.860
-5.520-2.14%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

JAZZ Financials

See Jazz Pharmaceuticals PLC's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Jazz Pharmaceuticals PLC Earnings Date

Latest Release
Aug 3, 2026
EPS / Forecast
--/6.18
Revenue / Forecast
--/1.12B
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
4.27B
4.88%
EPS(YoY)
-5.84
-164.48%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
412.01%4.74
5.53%3.33
18.29%4.14
-537.98%-11.74
-549.24%-1.52
109.83%3.16
50.53%3.50
64.25%2.68
-121.38%-0.23
139.42%1.50
--2.33
--1.63
--1.09
---3.82
--0.27
----
----
----
----
----
Revenue
19.05%1.07B
10.09%1.20B
6.74%1.13B
2.14%1.05B
-0.46%897.84M
7.53%1.09B
8.52%1.05B
6.95%1.02B
1.03%901.98M
4.10%1.01B
3.35%972.14M
2.62%957.32M
9.72%892.81M
8.41%972.12M
12.23%940.65M
24.08%932.88M
33.93%813.72M
34.74%896.73M
39.48%838.12M
33.67%751.81M
Net Profit
416.72%293.10M
6.45%203.45M
16.91%251.41M
-526.22%-718.47M
-533.06%-92.54M
102.98%191.12M
46.48%215.06M
61.40%168.57M
-121.06%-14.62M
139.11%94.15M
847.25%146.82M
201.28%104.44M
4114.94%69.42M
-580.95%-240.72M
62.81%-19.65M
109.54%34.66M
-98.65%1.65M
-126.50%-35.35M
-135.64%-52.83M
-416.47%-363.32M
Net Margin
366.04%27.42%
-3.30%16.98%
9.52%22.33%
-517.30%-68.71%
-535.98%-10.31%
88.76%17.56%
34.98%20.38%
50.92%16.46%
-120.84%-1.62%
137.57%9.30%
--15.10%
--10.91%
--7.78%
---24.76%
--0.62%
----
----
----
----
----
Gross Margin
0.27%71.34%
-0.75%73.01%
-1.20%73.60%
-0.98%73.38%
-1.39%71.15%
-1.15%73.57%
1.27%74.50%
0.24%74.10%
4.85%72.15%
8.41%74.43%
--73.56%
--73.93%
--68.81%
--68.65%
--68.93%
----
----
----
----
----
Debt to assets ratio
-2.97%45.15%
-9.64%45.99%
-5.34%47.21%
-2.42%49.01%
-7.70%46.53%
1.40%50.90%
-2.24%49.87%
-1.08%50.23%
-2.64%50.41%
-5.00%50.19%
--51.01%
--50.78%
--51.78%
--52.83%
--55.15%
----
----
----
----
----
Income Statement
Revenue
19.05%1.07B
10.09%1.20B
6.74%1.13B
2.14%1.05B
-0.46%897.84M
7.53%1.09B
8.52%1.05B
6.95%1.02B
1.03%901.98M
4.10%1.01B
3.35%972.14M
2.62%957.32M
9.72%892.81M
8.41%972.12M
12.23%940.65M
24.08%932.88M
33.93%813.72M
34.74%896.73M
39.48%838.12M
33.67%751.81M
Operating profit
482.52%213.80M
33.43%254.53M
-61.57%100.01M
9.79%218.97M
-173.34%-55.89M
19.53%190.77M
50.94%260.21M
26.52%199.44M
-40.02%76.21M
-26.76%159.60M
-32.24%172.39M
-21.88%157.64M
30.78%127.06M
149.95%217.91M
211.12%254.40M
236.83%201.79M
-40.08%97.15M
-58.37%87.18M
-60.35%81.77M
-70.21%59.91M
Net Profit
416.72%293.10M
6.45%203.45M
16.91%251.41M
-526.22%-718.47M
-533.06%-92.54M
102.98%191.12M
46.48%215.06M
61.40%168.57M
-121.06%-14.62M
139.11%94.15M
847.25%146.82M
201.28%104.44M
4114.94%69.42M
-580.95%-240.72M
62.81%-19.65M
109.54%34.66M
-98.65%1.65M
-126.50%-35.35M
-135.64%-52.83M
-416.47%-363.32M
Balance Sheet
Current assets
11.03%4.58B
-10.00%4.17B
-14.45%3.76B
-9.00%3.35B
16.61%4.13B
34.74%4.63B
35.27%4.39B
22.32%3.68B
27.12%3.54B
31.82%3.44B
26.22%3.25B
16.17%3.01B
11.35%2.78B
-0.20%2.61B
-2.16%2.57B
-12.29%2.59B
-21.03%2.50B
-8.04%2.61B
2.84%2.63B
28.30%2.95B
Total current liabilities
83.75%2.25B
115.92%2.24B
120.79%2.27B
33.11%2.07B
-21.74%1.22B
-32.42%1.04B
-34.54%1.03B
64.61%1.56B
71.88%1.56B
64.67%1.54B
93.53%1.57B
34.00%945.26M
23.26%908.90M
15.31%933.19M
10.60%812.95M
-19.89%705.44M
-1.95%737.41M
23.79%809.30M
14.47%735.05M
114.80%880.59M
Total assets
2.82%11.86B
-2.94%11.66B
-7.34%11.36B
-3.68%10.94B
1.83%11.53B
5.43%12.01B
9.39%12.26B
0.90%11.36B
2.53%11.33B
5.15%11.39B
7.89%11.20B
0.54%11.26B
-6.13%11.05B
-11.90%10.84B
-16.78%10.38B
-15.23%11.20B
74.19%11.77B
88.17%12.30B
98.32%12.48B
117.80%13.21B
Total liabilities
-0.44%7.33B
-7.30%7.34B
-8.50%7.40B
-4.76%7.24B
-3.55%7.36B
3.42%7.92B
4.80%8.08B
-1.75%7.60B
-1.06%7.63B
-1.20%7.66B
0.98%7.71B
-3.31%7.73B
-5.49%7.71B
-7.01%7.75B
-10.54%7.64B
-11.92%8.00B
175.80%8.16B
189.74%8.33B
192.98%8.54B
210.51%9.08B
Total equity
8.56%4.53B
5.49%4.32B
-5.08%3.96B
-1.49%3.71B
12.94%4.17B
9.55%4.09B
19.54%4.17B
6.72%3.76B
10.84%3.70B
21.11%3.74B
27.11%3.49B
10.15%3.53B
-7.58%3.34B
-22.18%3.09B
-30.30%2.75B
-22.53%3.20B
-4.98%3.61B
8.35%3.97B
16.62%3.94B
31.50%4.13B
Cash Flow Statement
Net operating income
-5.02%408.20M
-2.20%389.80M
19.03%474.62M
-73.18%88.86M
60.83%429.78M
138.19%398.58M
29.80%398.75M
11.65%331.35M
-16.68%267.23M
-51.07%167.34M
-26.51%307.19M
-2.07%296.76M
53.46%320.71M
92.38%341.97M
52.52%417.99M
626.79%303.04M
-26.67%208.98M
-4.57%177.75M
6.27%274.06M
-77.16%41.70M
Net investment
172.87%123.10M
-92.54%-372.16M
-253.12%-327.80M
-149.34%-641.02M
37.87%-168.93M
-289.87%-193.29M
222.83%214.09M
-199.85%-257.09M
-5538.82%-271.90M
131.38%101.80M
-3887.46%-174.30M
3.84%-85.74M
87.07%-4.82M
-3114.21%-324.38M
117.16%4.60M
98.49%-89.16M
-105.06%-37.29M
-113.78%-10.09M
90.41%-26.81M
-697.71%-5.91B
Net financing
90.35%-78.50M
1011.66%75.44M
-104.39%-10.83M
22.70%-124.53M
-1338.44%-813.47M
91.75%-8.28M
413.95%246.43M
-66.64%-161.09M
-89.85%-56.55M
-611.87%-100.31M
72.84%-78.49M
-996.98%-96.67M
89.00%-29.79M
107.95%19.60M
37.86%-289.05M
-99.77%10.78M
-1581.78%-270.81M
-541.33%-246.61M
-1953.24%-465.18M
625.88%4.66B

FAQs

What is the total revenue of Jazz Pharmaceuticals PLC?

According to Jazz Pharmaceuticals PLC's FY2025 earnings report, its total revenue reached 4.27B, with a year-on-year change of 4.07B.

What are the current assets of Jazz Pharmaceuticals PLC?

According to Jazz Pharmaceuticals PLC's FY2025 earnings report, its current assets were 4.17B, with a year-on-year change of -10.00.

What are the total assets of Jazz Pharmaceuticals PLC?

According to Jazz Pharmaceuticals PLC's FY2025 earnings report, its total assets of Jazz Pharmaceuticals PLC were 11.66B, with a year-on-year change of -2.94.

What are the total liabilities of Jazz Pharmaceuticals PLC?

According to Jazz Pharmaceuticals PLC's FY2025 earnings report, its total liabilities of Jazz Pharmaceuticals PLC were 7.34B, with a year-on-year change of -7.30.

What is the total equity of Jazz Pharmaceuticals PLC?

According to Jazz Pharmaceuticals PLC's FY2025 earnings report, its total equity of Jazz Pharmaceuticals PLC was 4.32B, with a year-on-year change of 5.49.

What is the net operating income of Jazz Pharmaceuticals PLC?

According to Jazz Pharmaceuticals PLC's FY2025 earnings report, its net operating income of Jazz Pharmaceuticals PLC was 517.62M, with a year-on-year change of -28.76.

What is the net investment of Jazz Pharmaceuticals PLC?

According to Jazz Pharmaceuticals PLC's FY2025 earnings report, its net investment of Jazz Pharmaceuticals PLC was -1.51B, with a year-on-year change of -197.11.

What is the net financing of Jazz Pharmaceuticals PLC?

According to Jazz Pharmaceuticals PLC's FY2025 earnings report, its net financing of Jazz Pharmaceuticals PLC was -873.38M, with a year-on-year change of -4357.07.

What is the Earnings Per Share (EPS) of Jazz Pharmaceuticals PLC?

According to Jazz Pharmaceuticals PLC's FY2025 earnings report, its Earnings Per Share (EPS) was -5.84, with a year-on-year change of -164.48.

What is the net income of Jazz Pharmaceuticals PLC?

According to Jazz Pharmaceuticals PLC's FY2025 earnings report, its net income was -356.15M, with a year-on-year change of -163.58.

What is the net margin of Jazz Pharmaceuticals PLC?

According to Jazz Pharmaceuticals PLC's FY2025 earnings report, its net profit margin was -8.39, with a year-on-year change of -160.98.

What is the gross margin of Jazz Pharmaceuticals PLC?

According to Jazz Pharmaceuticals PLC's FY2025 earnings report, its gross margin was 72.87, with a year-on-year change of -1.04.

What is the debt-to-asset ratio of Jazz Pharmaceuticals PLC?

According to Jazz Pharmaceuticals PLC's FY2025 earnings report, its debt-to-asset ratio was 45.99, with a year-on-year change of -9.64.

What is the Return on Equity (ROE) of Jazz Pharmaceuticals PLC?

According to Jazz Pharmaceuticals PLC's FY2025 earnings report, its Return on Equity (ROE) was -8.52, with a year-on-year change of -159.53.

What is the Return on Assets (ROA) of Jazz Pharmaceuticals PLC?

According to Jazz Pharmaceuticals PLC's FY2025 earnings report, its Return on Assets (ROA) was -3.03, with a year-on-year change of -163.24.

What is the operating profit of Jazz Pharmaceuticals PLC?

According to Jazz Pharmaceuticals PLC's FY2025 earnings report, its operating profit was 517.62M, with a year-on-year change of -28.76.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy